Non-Invasive Prediction of Necrotizing Enterocolitis in Preterm Neonates with Feeding Intolerance Using Fecal Lipocalin-2 and Electrical Cardiometry
1 other identifier
observational
42
1 country
1
Brief Summary
Prospective observational study to evaluate the efficiency of using electrical cardiometry in combination with fecal lipocalin-2 for prediction of NEC in preterm neonates with feeding intolerance
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2025
CompletedStudy Start
First participant enrolled
March 5, 2025
CompletedFirst Posted
Study publicly available on registry
March 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 5, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 5, 2026
ExpectedMarch 13, 2025
March 1, 2025
1 year
March 2, 2025
March 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Electrical cardiometry for prediction of NEC in preterm neonates with feeding intolerance
low cardiac output measured by electrical cardiometry predict NEC in preterm with feeding intolerance
48 hours
Secondary Outcomes (2)
Fecal lipocalin-2 for prediction of NEC in preterm neonates with feeding intolerance
48 hours
SMA flow in prediction of NEC in preterm neonates with feeding intolerance
48 hours
Study Arms (1)
feeing intolerance group
Preterm neonates with gestational age ≤ 35 weeks, admitted to the NICU, started enteral feeding and were diagnosed as having feeding intolerance defined as stages IA and IB by modified bell's staging. Measuring superior mesenteric artery will be done on day 1 of diagnosis of feeding intolerance Cardiac output and delivery of oxygen to tissues (do2) will be measured on day 1 of the diagnosis of feeding intolerance, and follow-up will be done after 24 hours by electrical bioimpedance. Fecal Lipocalin-2 assessment in Stool sample
Eligibility Criteria
Preterm neonates with gestational age ≤ 35 weeks, admitted to NICU, started enteral feeding and diagnosed as having feeding intolerance defined as stage IA and IB by modified bell's staging
You may qualify if:
- Preterm neonates with gestational age ≤ 35 weeks, admitted to NICU, started enteral feeding and diagnosed as having feeding intolerance defined as stage IA and IB by modified bell's staging
You may not qualify if:
- Chromosomal anomaly or multiple congenital malformations.
- Patient with surgical malformation of the intestinal tract (i.e. omphalocele, gastroschisis, malrotation, intestinal atresia)
- Patient diagnosed as hypoxic ischemic encephalopathy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of medicine, Ain Shams university.
Cairo, Abbasia, 11517, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant lecturer
Study Record Dates
First Submitted
March 2, 2025
First Posted
March 13, 2025
Study Start
March 5, 2025
Primary Completion
March 5, 2026
Study Completion (Estimated)
June 5, 2026
Last Updated
March 13, 2025
Record last verified: 2025-03